DNAJB6 mRNA expression (Hazard ratio = 1.522; p = 0.041) and tumor stage (Hazard ratio = 1.345; p < 0.001) were independent risk factors for progression-free survival (Figure 2I). This evidence concerns the gene DNAJB6 and neoplasm.